Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Sep 23, 2016 (Close)|
|Price (Rs)780.10||Open (Rs) 790.00||High (Rs) 792.20||Low (Rs) 778.00|
|% Change-0.81||Volume 238,625||Value (Rs) 187,753,090||52-Week H/L 933.70 / 706.40|
|Live NSE Quotes||Sep 23, 2016 (Close)|
|Price (Rs)780.05||Open (Rs) 790.10||High (Rs) 790.75||Low (Rs) 778.00|
|% Change-0.85||Volume 1,768,021||Value (Rs) 1,388,236,548||52-Week H/L 933.95 / 704.00|
|EPS (Rs)* 30.28||P/E Ratio (x) 25.77||Market Cap (Rs m) 1,615,711.92||P/BV (x) 5.14|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|SUN PHARMA Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.
Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.
Sun Pharma has announced its 2QFY16 results. The company has reported a 14.7% YoY decline in the topline, while net profits plummeted by 46% YoY. Here is our analysis of the results.
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.
Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.More Views on News
The finance minister at a recent conference got nostalgic about the Vajpayee era when rents were fairly close to EMIs.
Strong faith of foreign promoters in the Indian economy cements our long-term view on the Sensex.
Voltas and Tata Communications top performers under Cyrus Mistry.
Apurva Sheth talks about the sixth primary data point in futures and options market - Open Interest.
PersonalFN explains why instead of focusing merely on how much your fund manager earns, a holistic assessment is imperative to select mutual funds prudently for your investment portfolio.More